Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиUroGen Pharma Ltd. Мультипликаторы 2011-2024 | URGN
Мультипликаторы по годам UroGen Pharma Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.0 | -1.8 | -1.6 | -3.8 | -5.9 | -8.6 | -24.2 | - | - | - | - | - | - |
P/S |
5.0 | 3.0 | 3.6 | 41.3 | 34271.6 | 579.9 | 59.3 | - | - | - | - | - | - |
EPS |
-3.5 | -4.8 | -5.0 | -5.9 | -5.1 | -4.8 | -2.1 | -1.9 | -5.9 | - | - | - | - |
EV (Enterprise Value) |
562 млн | 363 млн | 239 млн | 460 млн | 589 млн | 566 млн | 454 млн | -14.6 млн | 3.11 млн | - | - | - | - |
EBITDA per Share |
-2.25 | -3.43 | -4.09 | -5.65 | -5.27 | -4.87 | -2.03 | - | - | - | - | - | - |
EV/EBITDA |
-2.4 | -3.5 | -5.2 | -7.2 | -22.6 | - | - | - | - | - | - | ||
PEG |
0.32 | -0.08 | - | 0.25 | 0.88 | 0.07 | 0.05 | - | - | - | - | - | - |
P/B |
-6.3 | -2.2 | 20.5 | 5.1 | 3.4 | 7.3 | 7.1 | - | - | - | - | - | - |
P/CF |
-5.4 | -2.2 | -2.0 | -4.5 | -8.6 | -17.3 | -49.1 | - | - | - | - | - | - |
ROE % |
156.79 | 122.85 | -1317.25 | -133.34 | -58.32 | -83.98 | -29.19 | - | - | - | - | - | - |
ROA % |
-57.34 | -80.95 | -92.55 | -105.31 | -51.95 | -73.06 | -26.47 | - | - | - | - | - | - |
ROCE % |
100.50 | 88.45 | -1097.02 | -126.02 | -59.85 | -85.67 | -29.12 | - | - | - | - | - | - |
Current Ratio |
0.7 | 0.6 | 1.1 | 5.4 | 7.6 | 7.6 | 10.6 | - | - | - | - | - | - |
DSO |
62.1 | 69.3 | 71.3 | 218.0 | - | - | - | - | - | - | - | - | - |
DIO |
194.9 | 218.3 | 240.5 | 710.5 | - | - | 192.2 | - | - | - | - | - | - |
DPO |
234.7 | 269.7 | 320.5 | 1183.3 | - | 864.8 | 2698.0 | - | - | - | - | - | - |
Операционный цикл |
257.0 | 287.6 | 311.8 | 928.5 | - | - | 192.2 | - | - | - | - | - | - |
Финансовый цикл |
22.3 | 17.8 | -8.7 | -254.8 | - | -864.8 | -2505.7 | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально UroGen Pharma Ltd.
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.68 | -1.03 | -1.3 | - | -1.13 | -1.18 | -1.25 | - | -1.35 | -1.17 | -1.17 | - | -1.31 | -1.44 | -1.79 | -1.86 | -1.06 | -1.08 | 1.11 | -1.46 | -1.28 | -1.14 | -0.88 | -0.74 | -0.02 | -0.7 | -1.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.41 | -0.65 | -0.94 | - | -0.78 | -0.82 | -0.96 | - | -1.04 | -1.01 | -1.17 | - | -1.32 | -1.46 | -1.82 | -1.89 | -1.12 | -1.14 | -1.15 | -1.48 | -1.3 | -1.16 | -0.88 | -0.74 | -0.02 | -0.65 | -1.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
136.27 | 124.99 | 172.79 | 272.34 | 176.55 | 39.94 | -71.90 | -176.30 | -206.21 | -140.32 | -126.25 | -101.66 | -123.28 | -105.71 | -85.65 | -58.32 | -63.02 | -73.47 | -81.02 | -83.98 | -72.37 | -49.97 | -38.33 | -49.38 | -34.66 | -34.27 | -25.90 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-83.46 | -92.27 | -85.22 | -55.50 | -77.95 | -80.29 | -79.08 | -66.12 | -89.74 | -90.91 | -99.56 | -80.29 | -99.55 | -86.92 | -72.33 | -51.95 | -55.60 | -64.43 | -70.73 | -73.06 | -63.51 | -43.68 | -26.27 | -13.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
28.58 | 57.16 | 102.90 | 202.92 | 128.60 | 25.69 | -60.61 | -149.02 | -179.25 | -135.15 | -127.59 | -103.25 | -125.34 | -108.00 | -88.03 | -60.30 | -64.87 | -75.39 | -82.82 | -85.67 | -73.83 | -50.82 | -38.40 | -50.08 | -35.25 | -34.86 | -26.82 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | 1.1 | 1.3 | 1.6 | 4.7 | 4.8 | 4.8 | 4.8 | 4.8 | 9.2 | 9.2 | 9.2 | 9.2 | 7.7 | 7.7 | 7.7 | 7.7 | 10.7 | - | - | - | 3.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
62.0 | 60.4 | 66.9 | - | 59.6 | 58.0 | 71.4 | - | 69.5 | 55.4 | 81.4 | - | 185.8 | 1728.6 | - | - | - | - | - | - | 55.5 | 29.6 | 0.4 | - | - | - | 199.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
192.6 | 195.2 | 197.2 | - | 223.8 | 242.3 | 286.9 | - | 265.1 | 215.9 | 269.3 | - | 580.0 | 3733.7 | - | - | - | - | - | - | 6.1 | 70.5 | 70.6 | - | - | - | 266.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
167.7 | 217.1 | 251.7 | - | 113.0 | 165.4 | 299.8 | - | 326.1 | 349.3 | 476.4 | - | 966.0 | 6218.3 | - | - | - | - | - | - | 369.5 | 1225.8 | 754.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
254.6 | 255.7 | 264.1 | - | 283.4 | 300.2 | 358.2 | - | 334.6 | 271.2 | 350.7 | - | 765.8 | 5462.2 | - | - | - | - | - | - | 61.6 | 100.0 | 70.9 | - | - | - | 465.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
86.9 | 38.5 | 12.4 | - | 170.4 | 134.9 | 58.4 | - | 8.6 | -78.1 | -125.8 | - | -200.2 | -756.1 | - | - | - | - | - | - | -307.9 | -1125.8 | -683.6 | - | - | - | 465.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD